Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 2,356,498 shares at $12.96 ($30.0M) on 2025-09-05, disclosed to the SEC on 2025-09-05.
Open-market sale of $30.0M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 1,195,000 | $14.9M | 49.8% |
| 2 | $12.92 | 194,933 | $2.5M | 8.4% |
| 3 | $12.92 | 194,933 | $2.5M | 8.4% |
| 4 | $12.96 | 385,816 | $5.0M | 16.7% |
| 5 | $12.96 | 385,816 | $5.0M | 16.7% |
| Total | $12.72 avg |
| 2,356,498 |
| $30.0M |
| 100% |
| Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |
| ROIV | SELL | 2025-05-08 | $13.3M | — | Filing → |